Evidence map›Paper›PMID 35515309›Full record

ArticleRSC advances2019

Antibacterial activity and mechanism of action of a thiophenyl substituted pyrimidine derivative.

Zhiyuan Fang, Yanan Li, Yuanyuan Zheng, Xiaomei Li, Yu-Jing Lu, Siu-Cheong Yan, Wing-Leung Wong, Kin-Fai Chan, Kwok-Yin Wong, Ning Sun

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. A Review on Medicinal Approaches of Novel Imatinib Derivatives.Current topics in medicinal chemistry · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhiyuan FangThe Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou 510700 P. R. China ning.sun@connect.polyu.hk +86-20-31758566.
Yanan LiDepartment of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai 519000 P. R. China.
Yuanyuan ZhengState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University Hung Hom Kowloon Hong Kong P. R. China.
Xiaomei LiThe Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou 510700 P. R. China ning.sun@connect.polyu.hk +86-20-31758566.
Yu-Jing LuDepartment of Pharmaceutical Engineering, Guangdong University of Technology Guangzhou 510006 P. R. China.
Siu-Cheong YanState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University Hung Hom Kowloon Hong Kong P. R. China.
Wing-Leung WongSchool of Biotechnology and Health Sciences, Wuyi University Jiangmen 529020 P. R. China.
Kin-Fai ChanState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University Hung Hom Kowloon Hong Kong P. R. China.
Kwok-Yin WongState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University Hung Hom Kowloon Hong Kong P. R. China.
Ning SunThe Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou 510700 P. R. China ning.sun@connect.polyu.hk +86-20-31758566.ORCID https://orcid.org/0000-0003-3500-9163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The issue of multidrug resistant bacteria is a worldwide health threat. To develop new antibacterial agents with new mechanisms of action is thus an urgent request to address this antibiotic resistance crisis. In the present study, a new thiophenyl-pyrimidine derivative was prepared and utilized as an effective antibacterial agent against Gram-positive strains. In the tests against MRSA and VREs, the compound showed higher antibacterial potency than that of vancomycin and methicillin. The mode of action is probably attributed to the effective inhibition of FtsZ polymerization, GTPase activity, and bacterial cell division, which cause bactericidal effects. The compound could be a potential candidate for further development as an effective antibiotic to combat drug-resistant bacteria.

Identifiers

PMID35515309
PMCPMC9062536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.